603392 万泰生物
已收盘 03-29 15:00:00
资讯
新帖
简况
万泰生物03月29日遭主力抛售5913万元 环比增加670.93%
自选股智能写手 · 15:17
万泰生物03月29日遭主力抛售5913万元 环比增加670.93%
万泰生物创1月新低 营收归母净利润同比大幅下滑
智选洞察 · 11:23
万泰生物创1月新低 营收归母净利润同比大幅下滑
医药早参|万泰生物2023年收入下滑50.73%;赛生药业宣布私有化
每日经济新闻 · 07:57
医药早参|万泰生物2023年收入下滑50.73%;赛生药业宣布私有化
万泰生物去年净利降七成:二价宫颈癌疫苗销售不及预期,此前中标价创新低
澎湃新闻 · 07:00
万泰生物去年净利降七成:二价宫颈癌疫苗销售不及预期,此前中标价创新低
V观财报|万泰生物:2023年净利润同比下降73.65%
中新经纬 · 03-28 22:16
V观财报|万泰生物:2023年净利润同比下降73.65%
万泰生物2023年净利12.48亿同比下滑73.65% 董事长邱子欣薪酬204.92万
挖贝网 · 03-28 21:36
万泰生物2023年净利12.48亿同比下滑73.65% 董事长邱子欣薪酬204.92万
万泰生物去年营收超55亿元,同比下降五成
新京报 · 03-28 20:36
万泰生物去年营收超55亿元,同比下降五成
万泰生物:去年营收55亿元 年内二价宫颈癌疫苗销售不及预期
贝壳财经 · 03-28 20:00
万泰生物:去年营收55亿元 年内二价宫颈癌疫苗销售不及预期
“馨可宁”采购价跌至86元/支,二价HPV疫苗价格战愈演愈烈|钛媒体焦点
钛媒体 · 03-28 19:15
“馨可宁”采购价跌至86元/支,二价HPV疫苗价格战愈演愈烈|钛媒体焦点
万泰生物将于4月19日召开股东大会,审议修订股东大会议事规则等议案
金融界网站 · 03-28 18:12
万泰生物将于4月19日召开股东大会,审议修订股东大会议事规则等议案
图解万泰生物年报:第四季度单季净利润同比减170.79%
证券之星 · 03-28 18:04
图解万泰生物年报:第四季度单季净利润同比减170.79%
万泰生物最新公告:2023年净利润同比下降73.65% 拟10派3.2元
证券之星 · 03-28 17:41
万泰生物最新公告:2023年净利润同比下降73.65% 拟10派3.2元
万泰生物(603392.SH)发布2023年度业绩,净利润12.48亿元,同比下降73.65%,拟10派3.2元
智通财经 · 03-28 17:28
万泰生物(603392.SH)发布2023年度业绩,净利润12.48亿元,同比下降73.65%,拟10派3.2元
万泰生物(603392.SH)终止实施2023年员工持股计划
智通财经 · 03-28 17:25
万泰生物(603392.SH)终止实施2023年员工持股计划
二价HPV疫苗,价格跌破100元
虎嗅网 · 03-28 12:05
二价HPV疫苗,价格跌破100元
生物疫苗概念盘中拉升,万泰生物涨2.70%
自选股智能写手 · 03-28 09:46
生物疫苗概念盘中拉升,万泰生物涨2.70%
万泰生物03月27日主力资金流出5317万元 连续3日减仓
自选股智能写手 · 03-27 15:18
万泰生物03月27日主力资金流出5317万元 连续3日减仓
北向资金3月26日净买入万泰生物11.98万股 连续5日增持
自选股智能写手 · 03-27 09:30
北向资金3月26日净买入万泰生物11.98万股 连续5日增持
新冠抗原检测概念盘中跳水,优宁维跌1.29%
自选股智能写手 · 03-22
新冠抗原检测概念盘中跳水,优宁维跌1.29%
万泰生物3月19日获融资净买入1257万元 环比增加5721.39%
自选股智能写手 · 03-21
万泰生物3月19日获融资净买入1257万元 环比增加5721.39%
加载更多
公司概况
公司名称:
北京万泰生物药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-04-29
主营业务:
北京万泰生物药业股份有限公司是从事体外诊断试剂、自动化检测设备、疫苗研发生产及销售的高新技术企业,其主要产品有疫苗、免疫诊断试剂、生化试剂、质控品、活性原料。公司获得国家企业技术中心、国家技术创新示范企业、国家地方联合工程实验室、国家知识产权优势企业、博士后科研工作站等95项省级及国家级荣誉称号;公司研发产品获得国家科学技术进步奖二等奖、国家技术发明奖二等奖、北京市科学技术一等奖、亚洲生物技术最佳创新奖及中国专利金奖等30项奖励。
发行价格:
8.75
{"stockData":{"symbol":"603392","market":"SH","secType":"STK","nameCN":"万泰生物","latestPrice":67.64,"timestamp":1711695600000,"preClose":69.44,"halted":0,"volume":7000498,"delay":0,"floatShares":1268000000,"shares":1268000000,"eps":-1.7667,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.8,"latestTime":"03-29 15:00:00","open":68.99,"high":68.99,"low":65.5,"amount":470000000,"amplitude":0.0503,"askPrice":67.64,"askSize":56,"bidPrice":67.63,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-1.7667,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1711935000000},"adr":0,"adjPreClose":69.44,"symbolType":"stock","openAndCloseTimeList":[[1711675800000,1711683000000],[1711688400000,1711695600000]],"highLimit":76.38,"lowLimit":62.5,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1268206999,"pbRate":6.75,"roa":"--","roe":"9.97%","epsLYR":0.99,"committee":-0.712018,"marketValue":85782000000,"floatMarketCap":85782000000,"peRate":-38.286069,"changeRate":-0.0259,"turnoverRate":0.0055,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-04-02。"},"requestUrl":"/m/hq/s/603392","defaultTab":"news","newsList":[{"id":"2423357433","title":"万泰生物03月29日遭主力抛售5913万元 环比增加670.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2423357433","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2423357433?lang=zh_cn&edition=full","pubTime":"2024-03-29 15:17","pubTimestamp":1711696663,"startTime":"0","endTime":"0","summary":"03月29日, 万泰生物股价跌2.59%,报收67.64元,成交金额4.70亿元,换手率0.55%,振幅5.03%,量比1.01。万泰生物今日主力资金净流出5913万元,连续5日净流出,上一交易日主力净流出767万元,今日环比增加670.93%。净流出前三个股分别为万泰生物、特宝生物、上海莱士。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291523358b710851&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291523358b710851&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423006521","title":"万泰生物创1月新低 营收归母净利润同比大幅下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2423006521","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2423006521?lang=zh_cn&edition=full","pubTime":"2024-03-29 11:23","pubTimestamp":1711682620,"startTime":"0","endTime":"0","summary":"消息解读万泰生物发布2023年年报,报告期内实现营收55.11亿元,同比下降50.73%;归母净利润为12.48亿元,同比下降73.65%。万泰生物表示,营收下降,与二价宫颈癌疫苗受九价宫颈癌疫苗扩龄影响以及市场竞争等因素影响,销售不及预期;2023年国内外新冠肺炎检测市场需求减少,体外诊断业务及原料相关收入出现大幅下降等有关。万泰生物的二价宫颈癌疫苗于2019年底获批上市,是首个国产宫颈癌疫苗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291126227a4fff34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291126227a4fff34&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423179638","title":"医药早参|万泰生物2023年收入下滑50.73%;赛生药业宣布私有化","url":"https://stock-news.laohu8.com/highlight/detail?id=2423179638","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2423179638?lang=zh_cn&edition=full","pubTime":"2024-03-29 07:57","pubTimestamp":1711670255,"startTime":"0","endTime":"0","summary":"NO.3 万泰生物2023年收入下滑50.73%3月28日,万泰生物发布2023年年报,报告期内实现营收55.11亿元,同比下降50.73%;归母净利润为12.48亿元,同比下降73.65%。NO.4 昭衍新药2023年收入23.76亿元昭衍新药3月28日披露2023年年报。公司称,报告期剔除大订单后收入54.05亿元,同比增长24.37%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032907583987c29dcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032907583987c29dcf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423173966","title":"万泰生物去年净利降七成:二价宫颈癌疫苗销售不及预期,此前中标价创新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2423173966","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2423173966?lang=zh_cn&edition=full","pubTime":"2024-03-29 07:00","pubTimestamp":1711666829,"startTime":"0","endTime":"0","summary":"二价宫颈癌疫苗刷新中标价新低后,万泰生物公布了2023年业绩。此前的业绩预减公告中,万泰生物称,二价宫颈癌疫苗收入较上年同期下降约42亿元。年报提到,万泰生物的疫苗主要包括戊肝疫苗、二价宫颈癌疫苗和鼻喷新冠疫苗。万泰生物中标信息在默沙东九价宫颈癌疫苗的强势竞争之下,国产二价宫颈癌疫苗目前在国内通过走政府采购。万泰生物的二价宫颈癌疫苗于2019年底获批上市,是首个国产宫颈癌疫苗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032907014687c27a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032907014687c27a30&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422118447","title":"V观财报|万泰生物:2023年净利润同比下降73.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422118447","media":"中新经纬","top":-1,"share":"https://www.laohu8.com/m/news/2422118447?lang=zh_cn&edition=full","pubTime":"2024-03-28 22:16","pubTimestamp":1711635402,"startTime":"0","endTime":"0","summary":"【V观财报|万泰生物:2023年净利润同比下降73.65%】万泰生物3月28日晚间披露年报,2023年实现营业收入55.11亿元,同比下降50.73%;归属于上市公司股东的净利润12.48亿元,同比下降73.65%。公司拟向全体股东每10股派发现金红利3.2元(含税)。(中新经纬APP)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032822174487c10857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032822174487c10857&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422194285","title":"万泰生物2023年净利12.48亿同比下滑73.65% 董事长邱子欣薪酬204.92万","url":"https://stock-news.laohu8.com/highlight/detail?id=2422194285","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2422194285?lang=zh_cn&edition=full","pubTime":"2024-03-28 21:36","pubTimestamp":1711632985,"startTime":"0","endTime":"0","summary":"报告期内经营活动产生的现金流量净额为1,537,822,927.19元,归属于上市公司股东的净资产12,700,597,999.65元。归属于上市公司股东的净利润1,247,679,723.81元,同比下滑73.65%,除上述营业收入影响因素外,同时受公司与新冠疫苗相关专用原料及成品、生产专用设备等资产减值事项对公司整体利润下滑影响。公告显示,报告期内董事、监事、高级管理人员报酬合计1,064.32万元。截至2023年12月31日,公司期末可供分配利润为1,843,857,613.16元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032821402787c0eb08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032821402787c0eb08&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422319587","title":"万泰生物去年营收超55亿元,同比下降五成","url":"https://stock-news.laohu8.com/highlight/detail?id=2422319587","media":"新京报","top":-1,"share":"https://www.laohu8.com/m/news/2422319587?lang=zh_cn&edition=full","pubTime":"2024-03-28 20:36","pubTimestamp":1711629415,"startTime":"0","endTime":"0","summary":"新京报讯 3月28日,万泰生物发布2023年年报,报告期内实现营收55.11亿元,同比下降50.73%;归属于母公司的净利润为12.48亿元,同比下降73.65%。基本每股收益0.99元,比上年同期下降73.88%。万泰生物表示,营收下降,与二价宫颈癌疫苗受九价宫颈癌疫苗扩龄影响以及市场竞争等因素影响,销售不及预期;2023年国内外新冠肺炎检测市场需求减少,体外诊断业务及原料相关收入出现大幅下降等有关。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403282038018b6dd1d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403282038018b6dd1d8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422167934","title":"万泰生物:去年营收55亿元 年内二价宫颈癌疫苗销售不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2422167934","media":"贝壳财经","top":-1,"share":"https://www.laohu8.com/m/news/2422167934?lang=zh_cn&edition=full","pubTime":"2024-03-28 20:00","pubTimestamp":1711627243,"startTime":"0","endTime":"0","summary":"报告期内,万泰生物疫苗产品的销售量为1571.11万支,同比减少41.94%。公司在年报中表示,营收下降主要由于二价HPV疫苗受九价HPV疫苗扩龄影响以及市场竞争等因素影响,销售不及预期,以及2023年国内外新冠肺炎检测市场需求减少,导致体外诊断业务及原料相关收入出现大幅下降。其中,2023年,万泰生物销售费用为15.95亿元,同比减少50.98%;管理费用约为3.53亿元,同比增长50.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403282001187a4fcfc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403282001187a4fcfc7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422161508","title":"“馨可宁”采购价跌至86元/支,二价HPV疫苗价格战愈演愈烈|钛媒体焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=2422161508","media":"钛媒体","top":-1,"share":"https://www.laohu8.com/m/news/2422161508?lang=zh_cn&edition=full","pubTime":"2024-03-28 19:15","pubTimestamp":1711624512,"startTime":"0","endTime":"0","summary":"据江苏省政府采购网近日消息,万泰生物旗下馨可宁采购价已跌破90元/支,意味着万泰生物今年对应板块的销售额还将进一步收缩,此前公司便发布公告预计2023年业绩大幅下滑,核心原因便是二价HPV疫苗销售额“腰斩”。一年后,馨可宁的价格从300元价格带降至200元价格带。2023年7月份,广东省发布2023年入学适龄女生HPV疫苗采购项目结果,万泰生物2价HPV疫苗中标单价为116元/针。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032819152687c06d8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032819152687c06d8a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422163345","title":"万泰生物将于4月19日召开股东大会,审议修订股东大会议事规则等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2422163345","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2422163345?lang=zh_cn&edition=full","pubTime":"2024-03-28 18:12","pubTimestamp":1711620752,"startTime":"0","endTime":"0","summary":"转自:金融界本文源自:金融界金融界3月28日消息,万泰生物发布公告,将于2024年4月19日召开年度股东大会,网络投票同日进行。股权登记日为4月12日,当日收市后持有万泰生物股票的投资者可以参与投票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281812418b6d5ac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281812418b6d5ac7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422508091","title":"图解万泰生物年报:第四季度单季净利润同比减170.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422508091","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422508091?lang=zh_cn&edition=full","pubTime":"2024-03-28 18:04","pubTimestamp":1711620291,"startTime":"0","endTime":"0","summary":"证券之星消息,万泰生物2023年年报显示,公司主营收入55.11亿元,同比下降50.73%;归母净利润12.48亿元,同比下降73.65%;扣非净利润10.78亿元,同比下降76.12%;其中2023年第四季度,公司单季度主营收入5.42亿元,同比下降78.62%;单季度归母净利润-5.61亿元,同比下降170.79%;单季度扣非净利润-5.94亿元,同比下降189.21%;负债率18.02%,投资收益9889.79万元,财务费用-9297.7万元,毛利率85.63%。财报数据概要请见下图:以上内容由证券之星根据公开信息整理,由算法生成,与本站立场无关。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032818072287c0317e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032818072287c0317e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422215400","title":"万泰生物最新公告:2023年净利润同比下降73.65% 拟10派3.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422215400","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422215400?lang=zh_cn&edition=full","pubTime":"2024-03-28 17:41","pubTimestamp":1711618875,"startTime":"0","endTime":"0","summary":"万泰生物披露年报,2023年实现营业收入55.11亿元,同比下降50.73%;净利润12.48亿元,同比下降73.65%;基本每股收益0.99元。公司拟向全体股东每10股派发现金红利3.2元(含税)。以上内容由证券之星根据公开信息整理,由算法生成,与本站立场无关。证券之星力求但不保证该信息(包括但不限于文字、视频、音频、数据及图表)全部或者部分内容的的准确性、完整性、有效性、及时性等,如存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281742208b6d3d97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281742208b6d3d97&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422152834","title":"万泰生物(603392.SH)发布2023年度业绩,净利润12.48亿元,同比下降73.65%,拟10派3.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422152834","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422152834?lang=zh_cn&edition=full","pubTime":"2024-03-28 17:28","pubTimestamp":1711618116,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万泰生物 披露2023年年度报告,公司2023年度实现营收55.11亿元,同比下降50.73%;归母净利润12.48亿元,同比下降73.65%;扣非净利润10.78亿元,同比下降76.12%;基本每股收益0.99元。归属于上市公司股东的净利润下降,除上述营业收入影响因素外,同时受公司与新冠疫苗相关专用原料及成品、生产专用设备等资产减值事项对公司整体利润下滑影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281730468b6d330c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281730468b6d330c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422151118","title":"万泰生物(603392.SH)终止实施2023年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2422151118","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422151118?lang=zh_cn&edition=full","pubTime":"2024-03-28 17:25","pubTimestamp":1711617945,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万泰生物(603392.SH)发布公告,鉴于目前国内外宏观经济、市场环境持续发生变化,公司2023年员工持股计划制定的公司层面业绩考核目标已不能与公司当前所处的市场经济状况相匹配,若继续实施2023年员工持股计划将难以达到预期激励目的和效果。结合公司实际情况、激励对象意愿和公司未来发展规划,为更好的维护公司、股东和员工的利益,有效调动核心员工的积极性,经慎重考虑,根据《关于上市公司实施员工持股计划试点的指导意见》《上海证券交易所上市公司自律监管指引第1号——规范运作》《2023年员工持股计划(草案)》等有关规定,公司决定终止实施本员工持股计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281727108b6d2fe5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281727108b6d2fe5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422189600","title":"二价HPV疫苗,价格跌破100元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422189600","media":"虎嗅网","top":-1,"share":"https://www.laohu8.com/m/news/2422189600?lang=zh_cn&edition=full","pubTime":"2024-03-28 12:05","pubTimestamp":1711598700,"startTime":"0","endTime":"0","summary":"当时,GSK的2价HPV疫苗全程接种费用为1740元。2022年,沃森生物的2价HPV疫苗上市,成为第二款获批上市的国产HPV疫苗。量价齐跌,使得万泰生物2023年HPV疫苗收入下降约42亿元。此次中标江苏省近50万支疫苗,单价仅86元。这导致,部分超龄女性只能选择接种2价和4价HPV疫苗。另一方面则是因为,默沙东4、9价HPV疫苗供应不足的情况,有所缓解。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281210138b6c1481&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281210138b6c1481&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422890592","title":"生物疫苗概念盘中拉升,万泰生物涨2.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422890592","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422890592?lang=zh_cn&edition=full","pubTime":"2024-03-28 09:46","pubTimestamp":1711590365,"startTime":"0","endTime":"0","summary":"03月28日,生物疫苗概念盘中拉升,截至09点46分,生物疫苗概念整体指数上涨0.52%,报1912.480点。从个股上来看,该概念的成分股中,万泰生物涨2.70%,东方嘉盛、万方发展、欧林生物涨幅居前。从资金上来看,截止发稿,生物疫苗概念主力净流入为-7426.31万,其中沃森生物受到资金热捧,主力净流入773.73万;拉长时间线来看,该板块近20日主力资金净流入-29.04亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328094605791d647b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328094605791d647b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422583499","title":"万泰生物03月27日主力资金流出5317万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2422583499","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422583499?lang=zh_cn&edition=full","pubTime":"2024-03-27 15:18","pubTimestamp":1711523923,"startTime":"0","endTime":"0","summary":"03月27日, 万泰生物股价跌4.17%,报收68.09元,成交金额4.17亿元,换手率0.48%,振幅4.07%,量比0.79。万泰生物今日主力资金净流出5317万元,连续3日净流出,上一交易日主力净流出4910万元,今日环比增加8.29%。该股近5个交易日下跌6.99%,主力资金累计净流出8066万元;近20日主力资金累计净流出1.96亿元,其中净流出天数为8日。净流出前三个股分别为万泰生物、智飞生物、沃森生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032715325187bb4282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032715325187bb4282&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422460135","title":"北向资金3月26日净买入万泰生物11.98万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2422460135","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422460135?lang=zh_cn&edition=full","pubTime":"2024-03-27 09:30","pubTimestamp":1711503024,"startTime":"0","endTime":"0","summary":"3月26日, 北向资金增持万泰生物11.98万股,连续5日增持。截止当日收盘,沪股通共持有万泰生物1564.55万股,占流通股1.23%。沪股通增持金额前五个股分别为招商银行、贵州茅台、紫金矿业、三一重工、兆易创新。万泰生物近5个交易日下跌2.60%,沪股通累计增持42.28万股;近20个交易日下跌4.00%,沪股通累计增持76.73万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032709342387b9eaa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032709342387b9eaa8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421833516","title":"新冠抗原检测概念盘中跳水,优宁维跌1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421833516","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421833516?lang=zh_cn&edition=full","pubTime":"2024-03-22 10:31","pubTimestamp":1711074702,"startTime":"0","endTime":"0","summary":"03月22日,新冠抗原检测概念盘中跳水,截至10点31分,新冠抗原检测概念整体指数下跌2.05%,报810.070点。从个股上来看,该概念的成分股中,优宁维跌1.29%,圣湘生物、安旭生物、万泰生物跌幅居前。从资金上来看,截止发稿,新冠抗原检测概念主力净流入为-2.58亿,其中万泰生物受到资金热捧,主力净流入1094.03万;拉长时间线来看,该板块近20日主力资金净流入-27.34亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032210314287e7ae41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032210314287e7ae41&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421603630","title":"万泰生物3月19日获融资净买入1257万元 环比增加5721.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421603630","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421603630?lang=zh_cn&edition=full","pubTime":"2024-03-21 10:00","pubTimestamp":1710986407,"startTime":"0","endTime":"0","summary":"3月19日,万泰生物获融资净买入1257万元,环比上一交易日增加5721.39%。其中,融资买入8513万元,融资偿还7256万元。融券方面,融券卖出6.17万股,当前融券余量为317.16万股。A股市场共有3338股获融资净买入,万泰生物净买入额排名第244。股市有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321100042879f8793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321100042879f8793&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-04-29","address":"北京市昌平区科学园路31号","stockEarnings":[{"period":"1week","weight":-0.0733},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.0757},{"period":"6month","weight":0.4473},{"period":"1year","weight":-0.1531},{"period":"ytd","weight":-0.0757}],"companyName":"北京万泰生物药业股份有限公司","boardCode":"AI0027","perCapita":"25863股","boardName":"医药制造业","registeredCapital":"126820万元","compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":-0.0016},{"period":"3month","weight":0.012},{"period":"6month","weight":-0.0321},{"period":"1year","weight":-0.0708},{"period":"ytd","weight":0.012}],"survey":" 北京万泰生物药业股份有限公司是从事体外诊断试剂、自动化检测设备、疫苗研发生产及销售的高新技术企业,其主要产品有疫苗、免疫诊断试剂、生化试剂、质控品、活性原料。公司获得国家企业技术中心、国家技术创新示范企业、国家地方联合工程实验室、国家知识产权优势企业、博士后科研工作站等95项省级及国家级荣誉称号;公司研发产品获得国家科学技术进步奖二等奖、国家技术发明奖二等奖、北京市科学技术一等奖、亚洲生物技术最佳创新奖及中国专利金奖等30项奖励。","serverTime":1711701185152,"listedPrice":8.75,"stockholders":"49035人(较上一季度减少2.20%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万泰生物,603392,万泰生物股票,万泰生物股票老虎,万泰生物股票老虎国际,万泰生物行情,万泰生物股票行情,万泰生物股价,万泰生物股市,万泰生物股票价格,万泰生物股票交易,万泰生物股票购买,万泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}